etoposide

FDA Drug Profile — Avopef, Etoposide

Drug Details

Generic Name
etoposide
Brand Names
Avopef, Etoposide
Application Number
NDA220200
Sponsor
Avyxa Pharma, LLC
NDC Codes
2
Dosage Forms
INJECTION, CAPSULE
Routes
INTRAVENOUS, ORAL
Active Ingredients
ETOPOSIDE

Indications and Usage

1 INDICATIONS AND USAGE ETOPOPHOS is a topoisomerase inhibitor indicated for the treatment of patients with: Refractory testicular tumors, in combination with other chemotherapeutic drugs. ( 1 ) Small cell lung cancer, in combination with cisplatin, as first-line treatment. ( 1 ) 1.1 Refractory Testicular Tumors ETOPOPHOS is indicated, in combination with other chemotherapeutic drugs, for treatment of patients with refractory testicular tumors. 1.2 Small Cell Lung Cancer ETOPOPHOS is indicated, in combination with cisplatin, for first-line treatment of patients with small cell lung cancer.